# Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma

> **NCT00800059** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Ottawa Hospital Research Institute** · enrollment: 27 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **RADIATION:** Total Marrow Irradiation

## Key facts

- **NCT ID:** NCT00800059
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2020-11
- **Final completion:** 2025-11
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2015-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800059, "Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00800059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*